ABOUT LINK ALTERNATIF MBL77

Not all people with CLL demand therapy. Irrespective of all current innovations, the iwCLL however endorses watchful observation for people with asymptomatic ailment.86 This recommendation relies on no less than two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104